Glycaemic, cardiorenal, and lipid parameters associated with SGLT2 inhibitors use in Indonesian patients with type 2 diabetes: 12-month multicenter real-world study.

Cokro F, Sauriasari R, Tahapary DL, Setiawan H, Tricaesario C, Hidayati N, Djauhari W, Tandradynata J, Soegondo S

Open source

DOI
10.1371/journal.pone.0353564
Published
2026
Container
PloS one
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0353564,
  title = {Glycaemic, cardiorenal, and lipid parameters associated with SGLT2 inhibitors use in Indonesian patients with type 2 diabetes: 12-month multicenter real-world study.},
  author = {Cokro F and Sauriasari R and Tahapary DL and Setiawan H and Tricaesario C and Hidayati N and Djauhari W and Tandradynata J and Soegondo S},
  year = {2026},
  journal = {PloS one},
  doi = {10.1371/journal.pone.0353564},
  url = {https://doi.org/10.1371/journal.pone.0353564}
}

RIS

TY  - JOUR
TI  - Glycaemic, cardiorenal, and lipid parameters associated with SGLT2 inhibitors use in Indonesian patients with type 2 diabetes: 12-month multicenter real-world study.
AU  - Cokro F
AU  - Sauriasari R
AU  - Tahapary DL
AU  - Setiawan H
AU  - Tricaesario C
AU  - Hidayati N
AU  - Djauhari W
AU  - Tandradynata J
AU  - Soegondo S
PY  - 2026
JO  - PloS one
DO  - 10.1371/journal.pone.0353564
UR  - https://doi.org/10.1371/journal.pone.0353564
ER  - 

APA

F, C., R, S., DL, T., H, S., C, T., N, H., W, D., J, T., & S, S. (2026). Glycaemic, cardiorenal, and lipid parameters associated with SGLT2 inhibitors use in Indonesian patients with type 2 diabetes: 12-month multicenter real-world study.. PloS one. https://doi.org/10.1371/journal.pone.0353564

Source records